Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMPRENAVIR vs AMRUBICIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMPRENAVIR vs AMRUBICIN: Safety Overview

Metric AMPRENAVIR AMRUBICIN
Total FAERS Reports 109 157
Deaths Reported 4 38
Death Rate 3.7% 24.2%
Hospitalizations 16 25
Average Patient Age 44.0 yrs 66.7 yrs
% Female Patients 25.0% 22.3%
FDA Approval Date Apr 15, 1999 N/A
Marketing Status Discontinued N/A